Mometasone Furoate is a moderately potent glucocorticoid steroid specifically developed for treating inflammatory skin disorders and respiratory conditions. It effectively addresse...

Mometasone Furoate is a moderately potent glucocorticoid steroid specifically developed for treating inflammatory skin disorders and respiratory conditions. It effectively addresses eczema, psoriasis, and allergic rhinitis, providing a reliable therapeutic solution for patients who do not respond adequately to less potent corticosteroids. With proven chemical stability and consistent efficacy, it serves as a trusted active pharmaceutical ingredient (API) for manufacturers developing high-quality medical products. Its molecular structure ensures targeted anti-inflammatory action, making it a preferred choice in pharmaceutical applications where precision, safety, and clinical results are paramount.

This steroid is extensively utilized across pharmaceutical manufacturing, healthcare, and dermatology sectors. Dermatologists and clinicians depend on it for formulating topical creams, ointments, and lotions to manage chronic skin conditions effectively. Additionally, it is incorporated into nasal sprays and inhalers for respiratory therapies, serving patients with asthma or allergic rhinitis. The pharmaceutical industry values its adaptability in both compounding pharmacies and large-scale drug production, ensuring compliance with international standards while meeting varied therapeutic requirements efficiently.

Businesses benefit from Mometasone Furoate due to its reliability, consistency, and proven performance. It offers a competitive advantage with its balanced potency—stronger than hydrocortisone yet safer than high-potency steroids—minimizing side-effect risks while delivering effective treatment outcomes. Its chemical stability, precise specifications, and adherence to regulatory requirements make it a low-risk, high-value investment for distributors and wholesalers serving global markets, ensuring customer satisfaction and repeat business.

Key Features:
- Moderately potent glucocorticoid steroid for targeted inflammation control
- Chemical formula C22H28Cl2O4 (Mometasone) and C27H30O6Cl2 (Furoate)
- Molecular mass of 427.361 g/mol (Mometasone) and 521.4 g/mol (Furoate)
- CAS numbers 105102-22-5 and 83919-23-7 for precise identification
- ATC codes D07AC13, D07XC03, R01AD09, and R03BA07 for versatile applications

Benefits:
- Effective relief for inflammatory skin conditions like eczema and psoriasis
- Trusted solution for respiratory issues including allergic rhinitis and asthma
- Balanced potency reduces side-effect risks compared to high-potency steroids
- Chemical stability ensures consistent performance in formulations
- Compliance with global regulatory standards for safe pharmaceutical use